Research Sample bioBank

Product ID: BBS0000-G2900433674100518D1 | Heart Failure | Clinical Research Sample

PRODUCT DATA SHEET

Product ID Name Origin Matrix Vial (ml) Qty. Avail. Type Price
BBS0000-G2900433674100518D1 Heart Failure Ukraine Serum
13.00
1.00 Diagnostic Clinical Samples $200.00
Gender:
Female
Patient Ethnicity:
Non-Hispanic
Storage Temp:
<-70C
Test 1:
ECG | Heart
Test Data 1:
150/90
Detail 1:
Sinus rhythm irregular. Deviation of the electrical axis of the heart to the left, single atrial extrasystoles 09/06/2019
Test 2:
Laboratory results
Test Data 2:
C-reactive protein (CRP) - 0.82 mg/l; Creatine Kinase-MB (CPK-MB) - 11 U/l; Troponin I - <0.1ng/ml; NT-proBNP - 36.63 pg/ml
Detail 2:
6-Sep-19
Test 3:
HIV I & II | HBV | HCV Results
Test Data 3:
Negative
Detail 3:
2019-09-06
Blood Type: Unknown
Co-morbidities: Chronic cholecystopancreatitis 01/01/2008, Arterial hypertension 01/01/2009
Current Medications: Trifas (Torasemide) 5 mg, Lisinopril 20 mg, Carvedilol 25 mg
Height: 64.56999999999999 in
Weight: 180 lbs
Is Pregnant: False
Menopausal Status: Postmenopausal
Smoking Notes: Non-Smoker
Symptoms: Shortness of breath during physical exertion, interruptions in the work of the heart, Cor-tons arrhythmic, emphasis II tone on the aorta, swelling of the legs.
X-Ray | Chest The heart is enlarged to the left, the lungs are clean, the roots are dense, and the broncho-vascular pattern is strengthened.
15-Jul-19
ECG | Heart Systolic metabolic dysfunction of the left ventricle persists. The wall of the left ventricle is not thickened.
6-Sep-19
Treatment of Comorbidities Trifas (Torasemide), Lisinopril, Magnicor (com drug: acetylsalicylic acid, magnesium hydroxide), Atorvacor (Atorvastatinum)
Diagnosis Arterial hypertension, grade II, stage II, risk II; Hypertensive retinal angiopathy in both eyes; Dysmetabolic cardiomyopathy; Heart failure, grade I. Functional class, grade I (NYHA).

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.